e-learning
resources
Vienna 2009
Monday, 14.09.2009
Diagnosis of pleural effusions and rare tumours experience
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The value of IL6 in differentiation between malignant and non malignant pleural effusion
H.H. Masoud, R. Emam, M. Gabr (Cairo, Egypt)
Source:
Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Session:
Diagnosis of pleural effusions and rare tumours experience
Session type:
E-Communication Session
Number:
1926
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H.H. Masoud, R. Emam, M. Gabr (Cairo, Egypt). The value of IL6 in differentiation between malignant and non malignant pleural effusion. Eur Respir J 2009; 34: Suppl. 53, 1926
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
N3 hilar sampling decision in the staging of mediastinal lung cancer
Asbestosis
Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis
Related content which might interest you:
Malignant pleural effusion cells show aberrant glucose metabolism gene expression
Source: Eur Respir J 2011; 37: 1453-1465
Year: 2011
Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012
Pentraxin-3: A novel biomarker for the differentiation of parapneumonic effusion and malignant pleural effusion
Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura
Year: 2012
Talc mediates angiostasis in malignant pleural effusions via endostatin induction
Source: Eur Respir J 2007; 29: 761-769
Year: 2007
Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010
C-reactive protein in differentiation between tuberculous and malignant pleural effusions
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011
Prognostic significance of pleural tumour burden in patients with malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010
Videothoracoscopy in the treatment of malignant pleural effusions
Source: Annual Congress 2009 - Pleural and mediastinal diseases
Year: 2009
The value of thoracoscopy in malignant pleural effusions
Source: Eur Respir J 2001; 18: Suppl. 33, 516s
Year: 2001
Transudative malignant pleural effusions
Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice?
Year: 2019
Interleukin-8 and other mediators are related to tumour burden in malignant pleural effusions (MPE)
Source: Eur Respir J 2007; 30: Suppl. 51, 103s
Year: 2007
Separating malignant from nonmalignant pleural effusion on the basis of
P
O
2
in pleural effusion
Source: Eur Respir J 2003; 22: Suppl. 45, 541s
Year: 2003
Expression of human mammaglobin gene in pleural effusion of patients affected by malignant pleural mesothelioma (MM)
Source: Eur Respir J 2004; 24: Suppl. 48, 81s
Year: 2004
Pleurodesis for malignant pleural effusion
Source: School Course 2014 - Medical Thoracoscopy
Year: 2014
Pleurodesis for malignant pleural effusion
Source: ERS Course 2016 - Skills course on medical thoracoscopy
Year: 2016
Comparison of telomerase activity in malignant and benign pleural effusions
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011
Osteopontin is important for malignant pleural effusion formation
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
Pleurodesis in the treatment of malignant pleural effusion
Source: Eur Respir J 2004; 24: Suppl. 48, 628s
Year: 2004
The presence of human mammaglobin transcripts in the pleural effusion is not predictive of survival in patients with malignant mesothelioma
Source: Annual Congress 2008 - Biology in thoracic tumours
Year: 2008
Usfulness of cholesterol in difering malignant and nonmalignant pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 246s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept